glp 1 agonist dpp 4 inhibitor The Role of GLP-1, DPP-4, and SGLT-2 Inhibitors in Diabetes Management 💊 DPP-4 INHIBITORS (GLIPTINS) Boost

Pump 2-3 times on dry hands and rub to warm the oil

PX: Writing original draft, Formal Analysis, Data curation

Neurological: convulsions, increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatment, vertigo, headache Endocrine: menstrual irregularities, development of cushingoid state, suppression of fetal intrauterine or childhood growth, lack of secondary response of the adrenal cortex or pituitary gland, particularly in situations of stress such as trauma, surgery or illness, decreased carbohydrate tolerance, manifestations of latent diabetes mellitus, increased requirements of insulin or oral hypoglycemic agents in diabetic patients Ophtalmic: posterior subcapsular cataracts, increased intraocular pressure, glaucoma, exophthalmos Metabolic: negative nitrogen balance due to protein catabolism Psychiatric: euphoria, mood swings, severe depression to frank psychotic manifestations, personality changes, hyperirritability, insomnia Others: anaphylactoid or hypertensive reactions and hypotension or shock-like reaction Cyanocobalamin and hydroxocobalamin: hypervitaminosis and side effects were not observed with their use Dosage and administration Adults Coated tablets: 1 coated tablet 2 times a day

Abosrea et al., 2023

Adequate IGF-1 levels in older adults are crucial for maintaining bone mass, muscle mass, and brain function